Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/10/829   
Active ingredient: Tesetaxel
Indication: Treatment of gastric cancer
Sponsor: Genta Development Limited
12A Upper Berkeley Street, London W1H 7QE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/12/2010 Orphan designation EMA/OD/101/10 (2010)9542 of 17/12/2010